4
Changes in Ownership
Spero Therapeutics, Inc. Filed Acc 0000899243-22-004594
Chief Medical Officer acquired 38,014 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Melnick David A. Chief Medical Officer | 2022-02-01 | Grant or award | +38,014 | 62,081 | D | ||
| Derivatives | |||||||
| Melnick David A. Chief Medical Officer | 2022-02-01 | Grant or award · Stock Option (Right to Buy) | +53,190 | 53,190 | D | ||
Loading xslF345X03/doc4.xml…